Clinical Investigations – Research Article

Kluger N.

Author affiliations

Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, Helsinki, Finland

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent via DeepDyve Unlimited fulltext viewing of this article Organize, annotate and mark up articles Printing and downloading restrictions apply

Start free trial

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

Received: December 12, 2022
Accepted: February 23, 2023
Published online: April 04, 2023

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 2

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Abstract

Introduction: The association between thyroid disorders (hyperthyroidism or hypothyroidism) and hidradenitis suppurativa is controversial. Our study aimed to determine the phenotype and comorbidities of HS patients with thyroid disorders. Methods: A retrospective study was conducted in the department of dermatology, Helsinki University Hospital, Finland, and included all the attending patients with HS diagnosis in 2018. Results: A total of 167 patients were included (97 women). The prevalence of thyroid disorders was 12% and of hypothyroidism 10.7%. Patients with thyroid disorders were more likely to have a BMI ≥25 (p = 0.016), asthma (p = 0.034) and to be nonsmoker (p = 0.018) or ex-smoker (p = 0.017). Binary logistic regression showed that only asthma and nonsmoking were associated with thyroid disorders or hypothyroidism among patients with HS. Conclusion: Our study is in line with previous ones that showed the association of HS and thyroid disorders in nonsmokers. Asthma may be simply an association with thyroid disorders and unrelated to HS as such.

© 2023 S. Karger AG, Basel

References Phan K, Huo YR, Charlton O, Smith SD. Hidradenitis suppurativa and thyroid disease: systematic review and meta-analysis. J Cutan Med Surg. 2020;24(1):23–7. Acharya P, Mathur M. Thyroid disorders in patients with hidradenitis suppurativa: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(2):491–3. Gau SY, Lee CY, Kuan YH, Ma KSK, Wei JCC. Hyperthyroidism and hypothyroidism in patients with hidradenitis suppurativa: a systematic review and meta-analysis. Int J Dermatol. 2023;62(3):e116–20. Sherman S, Tzur Bitan D, Kridin K, Pavlovsky L, Hodak E, Cohen AD. Hidradenitis suppurativa is associated with hypothyroidism and hyperthyroidism: a large-scale population-based study. Int J Dermatol. 2021;60(3):321–6. Liakou AI, Kontochristopoulos G, Marnelakis I, Tsantes AG, Papadakis M, Alevizou A, et al. Thyroid disease and active smoking may Be associated with more severe hidradenitis suppurativa: data from a prospective cross sectional single-center study. Dermatology. 2021;237(1):125–30. Chiricozzi A, Giovanardi G, Caposiena Caro DR, Iannone M, De Simone C, Cannizzaro MV, et al. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study. G Ital Dermatol Venereol. 2020;155(3):335–40. Kluger N, Ranta M, Serlachius M. The burden of hidradenitis suppurativa in a cohort of patients in Southern Finland: a Pilot Study. Skin Appendage Disord. 2017;3(1):20–7. Kluger N, Nuutinen P, Lybeck E, Ruohoalho T, Salava A. Type 2 diabetes mellitus in a cohort of Finnish patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34(2):e98–100. López-Llunell C, Romaní J, Garbayo-Salmons P, Agut-Busquet E. Vulvar hidradenitis suppurativa: clinical cross-sectional study of 25 patients. J Dermatol. 2021;48(4):457–63. Thyroid disease and asthma. Br Med J. 1977;2(6096):1173–4. Cardet JC, Bulkhi AA, Lockey RF. Nonrespiratory comorbidities in asthma. J Allergy Clin Immunol Pract. 2021;9(11):3887–97. Article / Publication Details

Received: December 12, 2022
Accepted: February 23, 2023
Published online: April 04, 2023

Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 2

ISSN: 2296-9195 (Print)
eISSN: 2296-9160 (Online)

For additional information: https://www.karger.com/SAD

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.